In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors

Magnetic Resonance in Medicine

Volumn 38, Issue 2, 1997, Pages 259-268

  Kovar, David A ^a   Lewis, Marta Z ^a   River, Jonathan N ^a   Lipton, Martin J ^a   Karczmar, Gregory S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Extraction fraction; Gd DTPA; Magnetic resonance; Perfusion rate

Indexed keywords

EXTRACTION; GADOLINIUM COMPOUNDS; MAGNETIC RESONANCE; MOLECULAR WEIGHT; MUSCLE; TRACERS; TUMORS;

CLINICAL PRACTICES; EVANS BLUE STAINING; EXTRACTION FRACTIONS; GD-DTPA; LOW MOLECULAR WEIGHT; MR CONTRAST AGENTS; PERFUSION RATE; SPATIALLY RESOLVED;

IMAGE PROCESSING;

CONTRAST MEDIUM; DEUTERIUM OXIDE; GADOLINIUM PENTETATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CAPILLARY PERMEABILITY; CONTRAST ENHANCEMENT; EXTRACTION; FEMALE; MATHEMATICAL COMPUTING; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; RAT;

EID: 0030750245     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910380215     Document Type: Article

References (63)

1. N. Weidner, J. Folkman, F. Pozza, P. Bevilacqua, E. N. Allred, D. H. Moore, S. Meli, G. Gasparini, Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 84, 1875-1851 (1992).
2. A. J. Guidi, L. Fischer, J. R. Harris, S. J. Schnitt, Microvessel density and distribution in ductal carcinoma in situ of the breast. J. Natl. Cancer Inst. 86, 614-619 (1994).
3. C. Frouge, J-M Guinebretier, G. Contesso, R. Di Paola, M. Blery, Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest. Radiol. 29, 1043-1049 (1994).
4. H. F. Dvorak, J. A. Nagy, B. Berse, L. F. Brown, K-T Yeo, T-K Yeo, A. M. Dvorak, L. van de Water, T. M. Sioussat, D. R. Senger, Vascular permeability factor, fibrin, the pathogenesis of tumor stroma formation. Ann. N.Y. Acad. Sci. 667, 101-111 (1992).
5. L. F. Brown, A. M. Dvorak, H. F. Dvorak, Leaky Vessels, Fibrin deposition and fibrosis: a sequence of events common to solid tumors and to many other types of disease. Am. Rev. Respir. Dis. 140, 1104-1107 (1989).
6. D. R. Senger, L. Van De Water, L. F. Brown, J. A. Nagy, K-T Yeo, T-K Yeo, B. Berse, R. W. Jackman, A. M. Dvorak, H. F. Dvorak, Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12, 303-324 (1993).
7. L. E. Gerlowski, R. K. Jain, Microvascular permeability of normal and neoplastic tissues. Microvasc. Res. 31, 288-305 (1986).
8. H. J. Weinmann, R. C. Brasch, W. R. Press, G. E. Wesbey, Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am. J. Roentol. 142, 619 (1984).
9. F. S. Prato, G. Wisenberg, T. P. Marshall, P. Uksik, P. Zabel, Comparison of the biodistribution of gadolinium-153 DTPA and technicium-99 M DTPA in rats. J. Nucl. Med. 29, 1683 (1988).
10. L. D. Diesbourg, F. S. Prato, G. Wisenberg, D. J. Drost, T. P. Marshall, S. E. Carroll, B. O'Neill, Quantification of myocardial blood flow and extracellular volumes using a bolus injection of gd-dtpa: kinetic modeling in canine ischemic disease. Magn. Reson. Med. 23, 239-253 (1992),
11. S-G Kim, J. J. H. Ackerman, Quantification of regional blood flow by monitoring of exogenous tracer via nuclear magnetic resonance spectroscopy. Magn. Reson. Med. 14, 266-282 (1990).
12. 31P NMR in vivo. II. Validation of the deuterium NMR washout method for measuring organ perfusion. Magn. Reson. Med. 25, 56-66 (1992).
13. 31P NMR in vivo. III. Alterations of muscle blood flow and metabolism during sepsis. Magn. Reson. Med. 25, 67-77 (1992).
14. 31P NMR in vivo. I. Assessment of absolute metabolite quantification. Magn. Reson. Med. 25, 45-55 (1992).
15. S-G Kim, J. J. H. Ackerman, Quantitative determination of tumor blood flow and perfusion via deuterium nuclear magnetic resonance spectroscopy in mice. Cancer Res. 48, 3449-3453 (1988).
16. J. Mattiello, J. L. Evelhoc, Relative volume-average murine tumor blood flow measurement via deuterium nuclear magnetic resonance spectroscopy. Magn. Reson. Med. 18, 320-334 (1991).
17. 2o clearance measurements of tumor blood flow in mice. Cancer Res. 50, 363-369 (1990).
18. M. R. Tripp, M. W. Meyer, S. Einzig, J. J. Leonard, C. R. Swayzee, J. Fox, Simultaneous regional myocardial blood flows by tritiated water and microspheres. Am. J. Physiol. 232, H173-H190 (1977).
19. F. M. Cohen, R. Kuwatsuru, S. Shames, M, Neuder, J. S. Mann, V. Vexler, W. Rosenau, R. C. Brasch, Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after x-irradiation. Invest. Radiol. 29, 970-977 (1994).
20. R. Jain, L. Gerlowshi, Extravascular transport in normal and tumor tissues. Crit. Rev. Onco. Hematol. 5, 115-170 (1984).
21. R. Jain, Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 6, 559-593 (1987).
22. R. Jain, Vascular and interstitial carriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev. 9, 253-266 (1990).
23. L. Baster, R. Jain, Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism. Microvasc. Res. 41, 5-23 (1991).
24. S. Seymour, Passive tumor targeting of soluble macromolecules and drug conjugate. Crit. Rev. Ther. Drug Carrier Syst. 9, 135-187 (1992).
25. K. P. Aicher, J. W. Dupon, D. L. White, S. L. Aukerman, M. E. Moseley, R. Juster, J. Rosenau, J. L. Winkelhate, R. C. Brasch, Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor alpha. Cancer Res. 50, 7376-7381 (1990).
26. H. Maeda, L. Seymour, Y. Miyamoto, Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjug. Chem. 3, 351-362 (1992).
27. C. Crone, D. G. Levitt, in "Handbook of Physiology", (E. Renkin, C. G. Michel, S. R. Geiger, Eds.), Vol IV, Print I, American Physiology Society, Bethesda, MD, 1984.
28. M. Inge, C. Bell, J. J. Freeman, A. Barna, Biochemical and morphologic properties of a new lactating mammary tumor line in the rat. Cancer Res. 25, 286-299 (1965).
29. C. E. Hayes, W. A. Edelstein, J. F. Schenck, O. M. Mueller, M. Eash, An Efficient, Highly homogeneous radiofrequency coil for whole-body nmr imaging at 1.5 T. J. Magn. Reson. 63, 622-628 (1985).
30. J. Tropp, The theory of the bird-cage resonator. J. Magn. Reson. 82, 51-62 (1989).
31. G. S. Karczmar, J. N. River, K. L. Liu, Detection of tumor perfusion using radio frequency gradients. J. Magn. Reson. Imaging 1, 203 (1991).
32. G. S. Karczmar, J. N. River, K. L. Liu, Non-invasive measurement of tumor perfusion by magnetic resonance, in "Proc., AUR, 39th Annual Meeting, Orlando, 1991," p. 87.
33. D. A. Kovar, G. S. Karczmar, Analysis of dynamic mr contrast uptake measurements: theory and application, in "Proc., ISMRM, 4th Scientific Meeting, New York, 1996," p. 1597.
34. D. M. Shames, R. Kuwatsuru, V. Vexler, A. Muhler, R. C. Brasch, Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique. Magn. Reson. Med. 29, 616-622 (1993).
35. M. M. Bahn, A single-step method for estimation of local cerebral blood volume from susceptibility contrast mri images. Magn. Reson. Med. 33, 309-317 (1995).
36. H. K. Thompson, C. F. Starmer, R. E. Whalen, H. D. McIntosh, Indicator transit time considered as a gamma variate. Circ. Res. 14, 502-515 (1964).
37. N. A. Lassen, W. Perl, "Tracer Kinetic Methods in Medical Physiology." pp. 1-189, Raven Press, New York, 1979.
38. 1H NMR studies of rat brain tumor ph and blood flow during acute hyperglycemie: differential effects between subcutaneous and intracerbral locations. Magn. Reson. Med. 12, 219-234 (1989).
39. L. A. Sappirstein, Regional blood flow by fractional distribution of indicators. Am. J. Physiol. 193, 161-168 (1958).
40. P. M. Parizel, B. A. A.M. van Hasselt, L. van den Hauwe, J. W. M. Van Goethem, A. M. A. DeSchepper. Effect of field strength on gadolinium enhancement in MR imaging. Eur. Radiol. 4, 557-560 (1994).
41. z-weighted contrasts in rapid low flip-angle imaging. Magn. Reson. Med. 5, 366-370 (1987).
42. K. Hittmair, G. Gomiscek, K. Langenberger, M. Recht, H. Imhof, J. Kramer, Method for quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn. Reson. Med. 31, 567-571 (1994).
43. R. B. Lauffer, in "Clinical Magnetic Resonance Imaging" (R. R. Edelmann, J. R. Hesselink, Eds.), p. 225. Saunders, Philadelphia, 1990.
44. E. C. Unger, K. Ugurhil, R. Latchan, Contrast agents for cerebral perfusion imaging. J. Magn. Reson. Imaging 4, 235-242 (1994).
45. S. D. Kennedy, L. S. Szcaopaniak, S. L. Gibson, R. Hilf, T. H. Foster, R. G. Bryant, Quantitative MRI of Gd-DTPA uptake in tumors: response to photodynamic therapy. Magn. Reson. Med. 31, 292-301 (1994)
46. S. Schaefer, R. A. Lange, P. V. Kulkarni, J. Katz. R. W. Parkey, J. T. Willerson, R. M. Peshock, In vivo NMR imaging of myocardial perfusion using the paramagnetic contrast agent manganesse gluconate. J. Am. College of Cardiol. 14, 472-80 (1989).
47. K. M. Donahue, D. Burstein, W. J. Manning, M. L. Gray, Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn. Reson. Med. 32, 66-76 (1994).
48. H-J Weinmann, M. Laniado, W. Mutzel, Pharmokinetics of Gd-DTPA/ dimeglumine after intravenous injection into healthy volunteers. Physiol. Chem. Physics Med. NMR 16, 167-173 (1984).
49. H-J Weinmann, R. C. Brasch, W-R Press, G. E. Wesbey, Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am. J. Roentgenol. 142, 619-624 (1984).
50. H. F. Dvorak, M. Detmar, K. P. Claffey, J. A. Nagy, L. van de Water, D. R. Senger, Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Inter. Arch. Allergy Immunol. 107, 233-235 (1995).
51. K. M. Donahue, D. Burstein, W. J. Manning, M. C. Gray, Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn. Reson. Med. 32, 66-76 (1994).
52. L. D. Diesbourg, F. S. Prato, G. Wisenberg, D. J. Drost, Marshall, S. E. Carroll, B. O'Neill, Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn. Reson. Med. 23, 239-253 (1992).
53. M. F. Wendland, M. Saeed, T. Masui, N. Derugin, M. E. Moseley, C. B. Higgins, Echo-planar MR imaging of normal and ischemic myocardium with gadodiamide injection. Radiology 186, 535-542 (1993).
54. D. A. Kovar, J. Mukherjee, M. Z. Lewis, M. J. Lipton, G. S. Karczmar, Uptake kinetics of a new highly permeable gadolinium-chelate, in "Proc, RSNA Scientific Program. Chicago, 1996," p. 391.
55. V. Y. Kuperman, G. S. Karczmar, M. J. K. Blomley, M. Z. Lewis, L. M. Lubich, M. J. Lipton, Differentiating between T1 and T2* changes caused by gadopentetate dimeglumine in the kidney by using a double-echo dynamic MR imaging sequence. J. Magn. Res. Imaging 6, 764-768 (1996).
56. I. K. Adzamli, M. Blau, M. A. Pfeffer, M. A. Davis, Phosphate-modified Gd-DTPA complexes III. The detection of myocardial infarction by MRI. Magn. Reson. Med. 29, 505-511 (1993).
57. S. Schaefer, C. R. Malloy, J. Katz, R. W. Parkey, L. M. Buja, J. T. Willerson, R. M. Peshock, Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. J. Am. College Cardiol. 12, 1064-72 (1988).
58. N. Wilke, C. Simm, J. Zhang, J. Ellermann, X. Ya, H. Merkle, G. Path, H. Ludemann, R. J. Bache, K. Ugurbil, Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn. Reson. Med. 29, 485-497 (1993).
59. N. Wilke, K. Kroll, H. Merkle, Y. Wang, Y. Ishibaski, Y. Xu, J. Zhang, M. Jerosch-Herold, A. Muhler, A. Stillmann, J. B. Bassingthwaighte, R. Bache, K. Ugurbil, Regional myocardial blood volume and flow: first pass MR imaging with polylysine-Gd-DTPA. J. Magn. Reson. Imaging 5, 227 (1995).
60. R. C. Brasch, Y. Berthezene, V. Vexler, W. Rosenau, O. Clement, A. Muhler, R. Kuwatsuru, D. M. Shames, Pulmonary oxygen toxicity; demonstration of abnormal capillary permeability using contrast-enhanced MRI. Ped. Rad. 23, 495-500 (1993).
61. M. Y. Su, J. C. Jao, O. Nalcioglu. Measurement of vascular volume fraction and blood tissue permeability constants with a pharmacokinetic model: studies of rat msucle tumors with dynamic Gd-DTPA enhanced MRI. Magn. Reson. Med. 32, 714-724 (1994).
62. D. M. Shames, R. Kuwatsuru, V. Vexler, A. Muhler, R. C. Brasch. Measurement of capillary permeability to macromolecules by dynamic resonance imaging: a quantitative noninvasive technique. Magn. Reson. Med. 29, 616-22 (1993).
63. P. S. Tofts, B. Berkowitz, M. D. Schnall. Quantitative analysis of dynamic Gd-DTPA enhancement of breat tumors using a permeability model. Magn. Reson. Med. 33, 564-568 (1995).